LIXTW Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 20:38):
Our systems believe the stock currently is overvalued by -0.49% compare to its pairs and should correct downwards.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases...

Stats
Dagens volum	1 720
Gjennomsnittsvolum	7 396
Markedsverdi	134 501
EPS	$-0.430 ( Q1 \| 2024-05-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -6.47%

ABCL 1.83%

ABCM 0.04%

ABEO -3.55%

ABIO -1.68%

ABOS 4.21%

ABSI 4.25%

ABUS -0.82%

ABVX -3.00%

ACAD 0.00%

ACER -17.95%

ACET -8.50%

ACGN 1.29%

ACHL -2.48%

ACHV 3.88%

ACIU -1.00%

ACLX 0.16%

ACRV -5.61%

ACST -1.68%

ACXP 3.92%

ADAG 6.07%

ADAP -2.70%

ADGI 0.87%

ADIL -1.70%

ADMA -1.86%

ADPT 0.74%

ADTX -2.78%

ADVM 1.09%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -3.36%

AGIO -2.12%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.10%

AKRO -2.51%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.80%

ALEC 0.00%

ALGS 1.32%

ALKS 1.84%

ALLK -11.44%

ALLO -3.97%

ALLR -2.55%

ALNA 3.16%

ALNY 1.84%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -14.17%

ALVR -0.69%

ALXN 0.00%

ALXO -13.61%

ALZN 4.02%

AMRN -1.88%

AMTI -3.13%

ANAB 1.17%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 1.86%

ANPC -3.15%

APGE 0.88%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.94%

APLT -0.45%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.66%

ARDS -12.13%

ARDX 0.91%

ARGX -0.43%

ARNA 0.00%

ARPO -0.90%

ARQT -2.86%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.91%

ARWR -1.67%

ASLN -3.43%

ASMB -4.22%

ASND -1.86%

ATAI -3.70%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.34%

ATRA -3.60%

ATXI 2.70%

ATXS -0.89%

AUPH -1.08%

AURA 4.86%

AUTL -3.45%

AVBP -3.26%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE -0.69%

AVTX -3.74%

AVXL -5.06%

AXLA 0.00%

AXSM -1.20%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.10%

BCAB -3.27%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.48%

BCRX 1.89%

BCTX 10.31%

BCTXW 13.02%

BCYC 0.95%

BDRX -4.06%

BDTX -0.32%

BEAM 2.35%

BFRA -2.91%

BGNE -2.03%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.47%

BLTE -1.13%

BLU 0.03%

BLUE -2.25%

BMEA -13.61%

BMRN 0.43%

BNOX 6.15%

BNTC -2.99%

BNTX -1.72%

BOLD -7.90%

BOLT -0.05%

BPMC -1.54%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -5.19%

BTAI 12.29%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 2.15%

CADL 0.80%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -1.08%

CARA -3.29%

CARM 6.96%

CASI 4.08%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.87%

CCXI 0.00%

CDAK 0.00%

CDIO -3.06%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.77%

CDXS 9.66%

CELC -3.24%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.18%

CGEN -3.31%

CGON -1.43%

CGTX -4.35%

CHMA -6.00%

CHRS 4.11%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.72%

CLGN 0.00%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.06%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.61%

CMPI 0.00%

CMPX -0.93%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 0.11%

CNTB -0.75%

CNTX -5.48%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.60%

COYA 1.14%

CPRX -1.75%

CRBP -0.93%

CRBU -7.10%

CRDF 2.21%

CRGX 0.10%

CRIS -1.59%

CRNX -6.34%

CRSP 0.00%

CRTX 2.63%

CRVO -3.23%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.16%

CUE -2.42%

CVAC -7.48%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.56%

CYTO 0.00%

DARE 3.54%

DAWN -0.96%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.32%

DNLI -1.90%

DNTH -5.07%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -3.12%

EDSA 4.09%

EFTR 5.21%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.65%

ELEV -1.24%

ELOX 10.77%

ELTX -5.15%

ELVN -2.14%

ELYM 5.12%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.33%

ENTO -4.97%

ENTX -0.53%

ENVB 4.67%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 1.20%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.07%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.01%

EVLO 0.00%

EWTX -1.09%

EXAI -0.19%

EXEL 0.56%

EYEG -0.69%

EYEN 0.59%

EYPT 1.69%

FATE -11.69%

FBIO 0.65%

FBIOP 0.87%

FBLG -7.23%

FBRX -0.02%

FDMT -5.00%

FENC -2.26%

FGEN -9.83%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.47%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.29%

FULC 2.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.67%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.65%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 5.01%

GLTO -3.31%

GLUE -3.43%

GLYC -11.78%

GMAB -0.45%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.42%

GNPX -3.40%

GNTA 3.94%

GOSS -10.12%

GOVX -1.82%

GOVXW 10.89%

GPCR -6.43%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.63%

GRTX -1.66%

GTHX 1.36%

GUTS 2.77%

GXGXW 41.67%

GYRE -4.54%

HALO -1.55%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -0.99%

HOOK 1.67%

HOTH -1.10%

HOWL 1.71%

HRMY 5.05%

HRTX 8.85%

HSTO 0.00%

HUMA 1.32%

HUMAW -6.26%

IBRX -5.78%

ICCC -3.10%

ICPT 0.21%

ICU 15.77%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.18%

IFRX -2.78%

IGMS -1.02%

IKNA -0.30%

IKT -9.93%

IMAB 0.58%

IMCR -3.41%

IMGN 0.02%

IMGO 0.00%

IMMP 4.94%

IMMX -6.90%

IMNM 4.59%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.04%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -3.26%

INAB -0.71%

INBX -2.66%

INCY -2.22%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 1.46%

INMB 4.31%

INO 1.95%

INSM -0.99%

INTS -1.96%

INVA 0.28%

INZY 2.29%

IOBT -10.24%

IONS 1.74%

IOVA -2.60%

IPA 3.00%

IPHA 3.05%

IPSC -2.73%

IRON -2.54%

ISEE 0.38%

ITOS 1.30%

ITRM 2.33%

IVA 6.96%

IVVD 0.00%

JAGX 1.57%

JANX -4.46%

JAZZ -0.87%

JNCE 0.00%

JSPR -1.60%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -5.47%

KALV -3.55%

KDNY 0.22%

KMPH -0.34%

KNSA -1.85%

KNTE -0.38%

KOD -7.71%

KPRX -4.08%

KPTI -8.90%

KRBP -10.00%

KRON 1.58%

KROS -0.37%

KRRO -2.22%

KRTX 0.03%

KRYS 0.51%

KTRA 12.70%

KTTA -0.65%

KTTAW 0.92%

KURA 0.59%

KYMR -2.87%

KYTX -3.88%

KZIA 4.41%

KZR -0.15%

LABP 0.57%

LBPH -0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.03%

LENZ -1.93%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -10.11%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.78%

LPCN -3.68%

LPTX -2.75%

LQDA 0.24%

LRMR 0.36%

LSTA -1.68%

LTRN 5.85%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -1.76%

LYEL -35.29%

LYRA 1.47%

MACK 0.10%

MBIO -11.36%

MBRX -1.43%

MCRB 3.08%

MDGL -2.32%

MDNA -13.16%

MDWD 3.56%

MDXG -2.14%

MEIP 0.00%

MESO -1.71%

MGNX -4.78%

MGTA -7.74%

MGTX -1.18%

MGX 2.14%

MIRM 0.57%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX 0.25%

MLYS -6.08%

MNKD -0.62%

MNMD 3.75%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.45%

MORF -3.34%

MREO -1.72%

MRKR -0.43%

MRNA -9.10%

MRNS -5.63%

MRSN -2.86%

MRTX -0.17%

MRUS -0.53%

MRVI 0.33%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.19%

MYMD 1.08%

NAMS 0.35%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.79%

NKGN 9.85%

NKGNW -18.03%

NKTR 3.27%

NKTX -3.75%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.71%

NMTR -42.97%

NOVN -24.84%

NRBO 14.94%

NRIX -0.53%

NRSN -4.82%

NRSNW 0.00%

NRXP -9.02%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.42%

NTRBW -31.07%

NUVL -0.87%

NVAX -7.79%

NVCT -7.49%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.80%

OCGN 8.04%

OCS -1.00%

OCUL 1.07%

OCUP 0.65%

ODT -4.27%

OKYO 2.15%

OLMA -4.94%

OMER -2.31%

OMGA 0.63%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -1.48%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.25%

OVID 0.63%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.70%

PCSA -1.93%

PCVX 0.00%

PDSB -6.65%

PEPG 1.19%

PGEN -6.29%

PHAR 2.19%

PHAS 0.00%

PHAT -0.68%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.74%

PLUR 7.39%

PMN -5.55%

PMVP -2.68%

PNT 0.16%

PPBT -6.87%

PRAX 7.30%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.18%

PRTA -2.74%

PRTC 0.62%

PRTG 4.25%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.71%

PTCT -0.61%

PTE -0.82%

PTGX -1.02%

PTIXW -48.41%

PULM 1.57%

PXMD 4.76%

PYPD 1.71%

PYXS 4.09%

QLGN -2.78%

QNCX 5.70%

QNRX 3.40%

QSI -30.09%

QSIAW -3.13%

QTTB 1.83%

QURE -0.78%

RAIN -1.63%

RANI 4.81%

RAPT -1.30%

RARE 1.66%

RCKT -9.98%

REGN -0.30%

RENB -3.12%

REPL -1.36%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -6.06%

RGNX -6.57%

RIGL -6.24%

RLAY -4.60%

RLMD 0.00%

RLYB -4.36%

RNA 1.88%

RNAC -4.53%

RNAZ -1.92%

RNXT 1.79%

ROIV -1.75%

ROIVW 4.56%

RPHM -1.40%

RPRX -0.58%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.59%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.81%

RYTM -6.12%

RYZB 0.02%

RZLT 3.62%

SABS -1.37%

SABSW -11.81%

SAGE -0.18%

SANA -2.40%

SAVA -1.50%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -3.85%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.48%

SGMT -5.08%

SGTX -2.56%

SIOX 22.63%

SLDB -2.93%

SLGL 5.23%

SLN -6.62%

SLNO 0.81%

SLRX 1.21%

SLS -2.56%

SMMT -3.27%

SNDX 3.28%

SNGX -0.38%

SNPX -2.55%

SONN -2.15%

SPPI -0.49%

SPRB -1.38%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.07%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -1.51%

STSA 0.00%

STTK 6.61%

SURF -0.93%

SVRA -0.42%

SWTX -0.11%

SYBX 1.29%

SYRS -1.72%

TALS -0.73%

TARA -7.14%

TARS -2.05%

TBPH 0.71%

TCBP 9.84%

TCDA 0.00%

TCON 1.37%

TCRR 0.00%

TCRT -1.75%

TCRX 4.82%

TECH -0.88%

TENX -0.32%

TERN -8.28%

TFFP -7.61%

TGTX -7.19%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.46%

TNXP -6.80%

TNYA -4.03%

TPST 6.08%

TRDA -4.67%

TRVI 3.07%

TRVN 0.82%

TSHA -18.86%

TSVT -3.73%

TTNP -6.05%

TVTX 3.27%

TYRA -6.65%

UBX -2.13%

UNCY -4.00%

URGN 2.06%

UTHR -0.06%

VACC 11.36%

VALN -6.70%

VAXX 94.50%

VBIV 0.93%

VBLT -8.77%

VCEL 1.11%

VCNX 9.03%

VCYT -0.75%

VERA -5.34%

VERU 2.62%

VERV -2.39%

VIGL -1.88%

VINC 2.93%

VIR -0.92%

VIRI -5.72%

VIRX 3.98%

VKTX -1.81%

VLON -13.04%

VNDA -4.07%

VOR -6.05%

VRCA 0.28%

VRDN -3.76%

VRNA -1.60%

VRPX 1.02%

VRTX 0.07%

VSTM 4.09%

VTGN -1.51%

VTVT 0.39%

VTYX -2.72%

VXRT -1.78%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -2.72%

WVE -8.91%

XBIO 1.03%

XBIT 6.88%

XCUR 3.77%

XENE -1.74%

XERS 4.76%

XFOR 4.69%

XLO 4.42%

XLRN 0.00%

XNCR 0.47%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.39%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.55%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-09-26	Van Der Baan Bastiaan Jeroen	Buy	250 000	Options to Purchase Common Stock
2023-10-03	Bernards Rene	Buy	5 527	Common Stock
2023-10-02	Bernards Rene	Buy	4 473	Common Stock
2023-10-03	Van Der Baan Bastiaan Jeroen	Buy	10 000	Common Stock
2023-10-02	Bernards Rene	Buy	4 473	Common Stock

INSIDER POWER
100.00
Last 33 transactions
Buy: 1 558 612 \| Sell: 83 334

Korrelasjon (AI algo v.1.1b): Overvalued: -0.49% $0.0601 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Lixte Biotechnology Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Lixte Biotechnology Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.66

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.66

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-39.85

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Lixte Biotechnology Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Lixte Biotechnology

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher\'s disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.